SCHEMBL6639980

SCHEMBL6639980

O=c1[nH]c2ccc(F)cc2c2c1CCC2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.50
▸ BRD3 Q15059 1/20 0.47
▸ ALDH1A1 P00352 3/20 0.46
▸ GAA P10253 2/20 0.46
▸ GLA P06280 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ KEAP1 Q14145 1/20 0.46
▸ NFE2L2 Q16236 1/20 0.46
▸ MAPKAPK2 P49137 1/20 0.45
▸ PARP1 P09874 1/20 0.44
▸ LMNA P02545 3/20 0.44
▸ MAPT P10636 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ FEN1 P39748 1/20 0.44
▸ BAZ2B Q9UIF8 1/20 0.44
▸ CCNB2 O95067 1/20 0.44
▸ CDK1 P06493 1/20 0.44
▸ CCNB1 P14635 1/20 0.44
▸ GSK3B P49841 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6646157 0.87 PARP1 (0.50) KDM4EALDH1A1PARP1LMNAHPGD
SCHEMBL4234216 0.81 KDM4E (0.68) KDM4EBRD3ALDH1A1GAAGLA
SCHEMBL6643889 0.80 ALDH1A1 (0.68) KDM4EALDH1A1HTTPARP1LMNA
SCHEMBL2550266 0.80 PARP1 (0.67) KDM4EALDH1A1GAAGLAMAPKAPK2
SCHEMBL6646914 0.80 KDM4E (0.51) KDM4EPARP1CCNB2CDK1CCNB1
SCHEMBL31154617 0.77 PARP1 (0.54) KDM4EALDH1A1GAAPARP1LMNA
SCHEMBL2553660 0.76 PARP1 (0.69) KDM4EALDH1A1MAPKAPK2PARP1LMNA
SCHEMBL6826753 0.76 MAPT (0.60) KDM4EALDH1A1LMNAMAPTBAZ2B
SCHEMBL4668622 0.75 MEN1 (0.66) KDM4EBRD3ALDH1A1GAAGLA
SCHEMBL30273084 0.75 MEN1 (0.66) KDM4EBRD3ALDH1A1GAAGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054869-B1 3,4-DIHYDROQUINOLINE DERIVATIVES AS NITROGEN MONOXIDE SYNTHASE (NOS) INHIBITORS SCHERING AG (DE) 2004-09-22 — — EP disclosed
US-6391887-B1 ANTIINFLAMMATORY AGENTS; AUTOIMMUNE DISEASE; CARDIOVASCULAR DISORDERS SCHERING AKTIENGESELLSCHAFT (DE) 2002-05-21 — — US disclosed
Send feedback